Correlation Analysis of Immune Function of Tuberculosis Patients Infected with COVID-19

Jihong LIU; Zhiqiang MA; Lin WANG; Xiaoyan WANG; Weiguang TIAN; Baoping LI; Rui DONG; Yujia LV

doi:10.12259/j.issn.2095-610X.S20240423

Volume 45 Issue 4

Apr. 2024

Turn off MathJax

Article Contents

Article Navigation > Journal of Kunming Medical University > 2024 > 45(4): 157-162

Jihong LIU, Zhiqiang MA, Lin WANG, Xiaoyan WANG, Weiguang TIAN, Baoping LI, Rui DONG, Yujia LV. Correlation Analysis of Immune Function of Tuberculosis Patients Infected with COVID-19[J]. Journal of Kunming Medical University, 2024, 45(4): 157-162. doi: 10.12259/j.issn.2095-610X.S20240423

Citation:

Jihong LIU, Zhiqiang MA, Lin WANG, Xiaoyan WANG, Weiguang TIAN, Baoping LI, Rui DONG, Yujia LV. Correlation Analysis of Immune Function of Tuberculosis Patients Infected with COVID-19[J]. Journal of Kunming Medical University, 2024, 45(4): 157-162. doi: 10.12259/j.issn.2095-610X.S20240423

Citation:

Jihong LIU, Zhiqiang MA, Lin WANG, Xiaoyan WANG, Weiguang TIAN, Baoping LI, Rui DONG, Yujia LV. Correlation Analysis of Immune Function of Tuberculosis Patients Infected with COVID-19[J]. Journal of Kunming Medical University, 2024, 45(4): 157-162. doi: 10.12259/j.issn.2095-610X.S20240423

PDF( 1084 KB)

Correlation Analysis of Immune Function of Tuberculosis Patients Infected with COVID-19

doi: 10.12259/j.issn.2095-610X.S20240423

The 3rd People’s Hospital of Kunming/ Yunnan Clinical Medical Center for Infectious Disease，Kunming Yunnan 650301，China

Received Date: 2023-12-28
Available Online: 2024-04-03
Publish Date: 2024-04-29

Abstract

Abstract

Objective To analyze the immunological indicators of TB patients co-infected with COVID-19, clarify their immune status, and explore the relationship and characteristics of relevant indicators with immune status. Methods The study group consisted of TB patients infected with COVID-19 admitted to the Third People's Hospital of Kunming City （n = 111）, while TB patients who were not infected with COVID-19 during the same period were selected as the control group （n = 1649） for the analysis of serum immunological indicators. Results After excluding confounding factors such as age and gender through PSM propensity matching, the TB-COVID group showed lower levels of CD19⁺, CD3⁺, CD4⁺, lymphocyte, and IL-8 compared to the TB group, while IL-10, IL-17, and IL-6 were higher in the TB-COVID group, with statistically significant differences （P < 0.05）. ROC curve analysis of the above differing indicators was performed to analyze the immune risk factors of TB-COVID. The sensitivity and specificity of CD19⁺, IL-10, and IL-6 for TB infection with COVID-19 were 71.4% and 56.7%, 59.1% and 77.0%, 59.1% and 77.7%, respectively. The AUC values were 0.659 （95%CI: 0.583～0.736, P < 0.05）, 0.645 （95%CI: 0.558～0.732, P < 0.05）, and 0.649 （95%CI: 0.564～0.734, P < 0.05）. When comparing subgroups based on age, in the TB-COVID group, IL-1β, IL-2, IL-4, IL-8, TFN-α, and IL-12p70 sharply increased in the 21-40 age group far beyond the TB group, and gradually declined with increasing age. Conclusion TB patients have a weakened immune system after being infected with COVID-19, with multiple immune indicators lower compared to TB patients. This is related to cell immunity and cytokine storm, so we need to pay more attention to TB-COVID cases.
- Tuberculosis,
- COVID-19,
- Immune function,
- Co-infection

FullText(HTML)

References(22)

References

[1]	WHO. Global tuberculosis report 2023; World Health Organization [EB/OL]. [2023-11-7]. https://www.who.int/teams/global-tuberculosis-programme/tb-reports.
[2]	Bagcchi S. WHO's global tuberculosis report 2022[J]. Lancet Microbe,2023,4(1):e20. doi: 10.1016/S2666-5247(22)00359-7
[3]	Azkur A K,Akdis M,Azkur D,et al. Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19[J]. Allergy,2020,75(7):1564-1581. doi: 10.1111/all.14364
[4]	Sokolowska M,Lukasik Z M,Agache I,et al. Immunology of COVID-19: Mechanisms,clinical outcome,diagnostics,and perspectives-a report of the European Academy of Allergy and Clinical Immunology (EAACI)[J]. Allergy,2020,75(10):2445-2476. doi: 10.1111/all.14462
[5]	Zhang H P,Sun Y L,Wang Y F,et al. Recent developments in the immunopathology of COVID-19[J]. Allergy,2023,78(2):369-388. doi: 10.1111/all.15593
[6]	TB/COVID-19 global study group. Tuberculosis and COVID-19 co-infection: Description of the global cohort[J]. Eur Respir J,2022,59(3):262.
[7]	Luke E,Swafford K,Shirazi G,et al. TB and COVID-19: an exploration of the characteristics and resulting complications of co-infection[J]. Front Biosci (Schol Ed),2022,14(1):6.
[8]	高雯琬, 郭建琼, 李同心, 等. 《结核病免疫治疗专家共识（2022年版）》要点解读[J]. 结核与肺部疾病杂志, 2023, 4（3）: 194-197.
[9]	Wik J A,Skålhegg B S. T cell metabolism in infection[J]. Front Immunol,2022,13:840610. doi: 10.3389/fimmu.2022.840610
[10]	de Martino M,Lodi L,Galli L,Chiappini E. Immune response to mycobacterium tuberculosis: A narrative review[J]. Front Pediatr,2019,7:350. doi: 10.3389/fped.2019.00350
[11]	邓小博,马欢欢,俞荣,等. 新冠病毒感染后细胞免疫研究进展[J]. 中华医院感染学杂志,2022,32(10):1590-1595.
[12]	王黎霞,成诗明,周林,等. 肺结核诊断 WS 288—2017[J]. 中国感染控制杂志,2018,17(7):642-652.
[13]	中国国家卫生委编委. 新型冠状病毒感染诊疗方案(试行第十版)[J]. 传染病信息,2023,36(1):18-25.
[14]	Visca D,Ong C W M,Tiberi S,et al. Tuberculosis and COVID-19 interaction: A review of biological,clinical and public health effects[J]. Pulmonology,2021,27(2):151-165. doi: 10.1016/j.pulmoe.2020.12.012
[15]	Ahmed A,Vyakarnam A. Emerging patterns of regulatory T cell function in tuberculosis[J]. Clin Exp Immunol,2020,202(3):273-287. doi: 10.1111/cei.13488
[16]	Hu B,Huang S,Yin L. The cytokine storm and COVID-19[J]. J Med Virol,2021,93(1):250-256. doi: 10.1002/jmv.26232
[17]	Riou C,du Bruyn E,Stek C,et al. Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection[J]. J Clin Invest,2021,131(12):e149125. doi: 10.1172/JCI149125
[18]	Jarczak D,Nierhaus A. Cytokine Storm-Definition,causes,and implications[J]. Int J Mol Sci,2022,23(19):11740. doi: 10.3390/ijms231911740
[19]	Yang L,Xie X,Tu Z,et al. The signal pathways and treatment of cytokine storm in COVID-19[J]. Signal Transduct Target Ther,2021,6(1):255. doi: 10.1038/s41392-021-00679-0
[20]	Murakami M,Kamimura D,Hirano T. Pleiotropy and specificity: Insights from the interleukin 6 family of cytokines[J]. Immunity,2019,50(4):812-831. doi: 10.1016/j.immuni.2019.03.027
[21]	Moore J B,June C H. Cytokine release syndrome in severe COVID-19[J]. Science,2020,368(6490):473-474. doi: 10.1126/science.abb8925
[22]	Swanepoel J,van der Zalm M M,Preiser W,et al. SARS-CoV-2 infection and pulmonary tuberculosis in children and adolescents: A case-control study[J]. BMC Infect Dis,2023,23(1):442. doi: 10.1186/s12879-023-08412-8

Relative Articles(20)

Relative Articles

[1]	Lingjun SHEN, Longfen LI, Chunjing SHI, Wenming LI, Yuanqing HUANG, Huajie ZHANG, Yun LUO, jie LI, Li LIU. Factors Influencing the Development of Extra-Pulmonary Tuberculosis in Patients with Viral Hepatitis Complicated by Pulmonary Tuberculosis. Journal of Kunming Medical University, 2024, 46(): 1-7.
[2]	Ying ZHANG, Fengxia YANG, Jing GUO, Qingling ZHANG. Effects of Systematic Psychological Intervention Based on S-ABC Framework on Perioperative Psychological Distress and Immune Function in Patients with Primary Liver Cancer. Journal of Kunming Medical University, 2023, 44(11): 170-174. doi: 10.12259/j.issn.2095-610X.S20231126
[3]	Lin WANG, Lingjun SHEN, Haiwen LI, Xiaoyan WANG, Jianpeng GAO, Zhiqiang MA. Analysis of Nutritional Status and Immune Function of Tuberculosis Patients in Yunnan. Journal of Kunming Medical University, 2023, 44(1): 109-115. doi: 10.12259/j.issn.2095-610X.S20230116
[4]	Ling HE, Zehao YU. Correlation between CD3⁺ HLA-DR Expression and Vita Level in Severe Mycoplasma Pneumoniae Pneumonia. Journal of Kunming Medical University, 2022, 43(5): 103-107. doi: 10.12259/j.issn.2095-610X.S20220528
[5]	Nihong LU, Honglu LIU, Jiawei XIA, Yangjun CHEN, Linjun SHEN, Yongrui YANG, Jie LI. Clinical Evaluation of Immune Function and SAA, MMP-9 and MMP-14 in Liver Injury Caused by Anti-Tuberculous Drugs. Journal of Kunming Medical University, 2022, 43(4): 50-54. doi: 10.12259/j.issn.2095-610X.S20220410
[6]	Na LI, Jie CHEN, Ji LUO, Yong-gang CHEN, Jiang-li PENG, Ming-li YU, Sheng-hao LI. Retrospective Analysis of 376 Cases of Adverse Reactions to Antituberculosis Drug. Journal of Kunming Medical University, 2021, 42(4): 117-121. doi: 10.12259/j.issn.2095-610X.S20210422
[7]	Zhe GE, Si-ping LU, Shi-zhong FU, Chun-hong WANG, Shao-ying LI, Ao LIU. The Preliminary Application of Whole Blood Interferon-Gamma Release Assay Combined with T Lymphocyte Subset Detection in Diagnosis of Pulmonary Tuberculosis. Journal of Kunming Medical University, 2021, 42(9): 108-113. doi: 10.12259/j.issn.2095-610X.S20210901
[8]	Xi-song MIAO, Shan YU. Investigation on Sleep Disorders in Medical Students in An University during COVID-19 Pandemic. Journal of Kunming Medical University, 2021, 42(3): 166-169. doi: 10.12259/j.issn.2095-610X.S20210338
[9]	Xing LIU, Bing OUYANG, Na LI, Ji LUO, Xu-qin SHI, Jie CHEN, Hui SUN, Hai-wen LI. Effect and Economic Evaluation of the Combination of Traditional Chinese and Western Medicine in Treatment of MDR-TB. Journal of Kunming Medical University, 2020, 41(11): 49-55. doi: 10.12259/j.issn.2095-610X.S20201106
[10]	Rong WAN, Ming-wu LI, Meng MA, Ming-hong LAI, Guang-mei Li. Efficacy of T-SPOT.TB in Treatment of Active Tuberculosis. Journal of Kunming Medical University, 2020, 41(12): 133-137. doi: 10.12259/j.issn.2095-610X.S20201237
[11]	Ran Hai Liang , Yang Qing Huan , Chen Ying , Xiong Li Fen , Deng Yi Yu , He Xiu Yun . . Journal of Kunming Medical University, 2020, 41(06): 46-50.
[12]	Liu Li , Wang Ya Ling , Bai Jing Song , Wang Li Xi , Wang Wei Bo , Chen Xiao Juan . Application of Cluster Nursing in Mechanical Ventilation Treatment of HIV Infection Complicated with Pulmonary Tuberculosis. Journal of Kunming Medical University, 2017, 38(07): 147-150.
[13]	Hong Xu Hua . Effects of Tuberculosis Drugs Combined with Rifapentine on the Immune Function， Inflammatory Factors， VEGF and MMP-9 of TB Patients. Journal of Kunming Medical University,
[14]	Lu Ni Hong . . Journal of Kunming Medical University,
[15]	Lu Ni Hong . . Journal of Kunming Medical University,
[16]	Gu Xin . . Journal of Kunming Medical University,
[17]	Lu Ni Hong . Clinical Characteristics of Pulmonary Tuberculosis Patients with and without HIV(+)/AIDS. Journal of Kunming Medical University,
[18]	Shen Li Da . . Journal of Kunming Medical University,
[19]	. The Value of T Cells Spots Test in the Diagnosis of Human Immunodeficiency Virus Amalgamative Tuberculosis Pateints with Different Levels of T cells. Journal of Kunming Medical University,
[20]	Zhang Yan Li . . Journal of Kunming Medical University,